|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8704
|
|
pubmed:dateCreated |
1990-7-24
|
|
pubmed:abstractText |
Patients with Alzheimer disease (AD) had reduced regional cerebral blood flow (rCBF) in the posterior parietotemporal region compared with controls, as determined with technetium-99m hexamethyl propyleneamine oxime and single photon emission tomography. Central cholinergic stimulation with physostigmine produced a focal increase in rCBF in the posterior parietotemporal region in the patients with AD but not in controls.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
23
|
|
pubmed:volume |
335
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1484-7
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:1972432-Aged,
pubmed-meshheading:1972432-Alzheimer Disease,
pubmed-meshheading:1972432-Analysis of Variance,
pubmed-meshheading:1972432-Cerebrovascular Circulation,
pubmed-meshheading:1972432-Drug Evaluation,
pubmed-meshheading:1972432-Female,
pubmed-meshheading:1972432-Glycopyrrolate,
pubmed-meshheading:1972432-Humans,
pubmed-meshheading:1972432-Infusions, Intravenous,
pubmed-meshheading:1972432-Male,
pubmed-meshheading:1972432-Middle Aged,
pubmed-meshheading:1972432-Organotechnetium Compounds,
pubmed-meshheading:1972432-Oximes,
pubmed-meshheading:1972432-Parasympathetic Nervous System,
pubmed-meshheading:1972432-Parietal Lobe,
pubmed-meshheading:1972432-Physostigmine,
pubmed-meshheading:1972432-Technetium Tc 99m Exametazime,
pubmed-meshheading:1972432-Temporal Lobe,
pubmed-meshheading:1972432-Tomography, Emission-Computed, Single-Photon
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease.
|
|
pubmed:affiliation |
University of Oxford, Department of Psychiatry, Warneford Hospital, UK.
|
|
pubmed:publicationType |
Journal Article
|
